Does CMV Reactivation Cause Functional Impairment of CMV Specific CD4+ T-Cells? The Potential for Valaciclovir to Prevent CMV-Mediated Adverse Modulation of the Immune System in Patients with ANCA-Associated Vasculitis

Project Details

Short titleDoes CMV Reactivation Cause Functional Impairment of CMV Specific CD4+ T-Cells? The Potential for Valaciclovir to Prevent CMV-Mediated Adverse Modulation of the Immune System in Patients with ANCA-Associated Vasculitis
StatusFinished
Effective start/end date1/08/12 → 31/10/19

Funding

  • The Wellcome Trust
  • VASCULITIS UK